Reyataz · DIN 02248611 · 200 mg · capsule
General benefit; Health Canada lists this DIN as Cancelled post market since 2026-07-30 — choose a marketed DIN from the same-category list.Discontinued July 30, 2026 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2026-07-30 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2026-07-30 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Reyataz · DIN 02248611
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 2004-11-04
Health Canada: Cancelled post market since 2026-07-30 · brand REYATAZ · ATC J05AE08 ATAZANAVIR · form Capsule · route Oral · ingredients ATAZANAVIR (ATAZANAVIR SULFATE) 200 MG · company Bristol-myers squibb canada · schedule Prescription
Ministry pays: $2.8552 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248611)
Source record
DIN 02248611: Reyataz
Raw flags: sec3=Y
Item: 081800081; group id 64; item number 0127; lccId None; manufacturer id BQU
Source form: Cap; strength: 200mg
Recorded listing: General benefit
Source prices (unrounded): $11.7633; ministry $2.8552
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248611
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72967
Interchangeable products
Jamp Atazanavir · DIN 02513110 · $2.8552
Mylan-Atazanavir · DIN 02456885 · $2.8552
Teva-Atazanavir · DIN 02443813 · $2.8552
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since July 30, 2026 — choose a marketed DIN from the same-category list.